house · trading 2014-12-03 → 2026-06-30
*Purchases reported over roughly the last three years, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings state a range, never a share count, so this tracks the stock rather than the position. It is not a dollar figure and it is not what this member made.
By recent-buy return, Virginia Foxx ranks #71 of 118 lawmakers — in the bottom 60%.
▮ buys · ▮ sells
| Date | Ticker | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2021-12-13 | XOM | BUY | $1K–$15K | $61.63 | $179.91 2026-10-27 | +191.9% |
| 2021-11-30 | PBA | BUY | $1K–$15K | $29.65 | $49.95 2026-10-27 | +68.5% |
| 2021-11-26 | PAA | BUY | $15K–$50K | $9.90 | $26.41 2026-10-27 | +166.8% |
| 2021-11-26 | BXMT | BUY | $15K–$50K | $30.90 | $10.69 2026-10-27 | -65.4% |
| 2021-11-23 | PM | BUY | $1K–$15K | $89.65 | $182.53 2026-09-04 | +103.6% |
| 2021-11-19 | ILPT | BUY | $1K–$15K | $23.26 | $7.38 2026-10-27 | -68.3% |
| 2021-11-19 | EPD | BUY | $1K–$15K | $21.70 | $37.17 2026-10-27 | +71.3% |
| 2021-11-15 | PAA | BUY | $1K–$15K | $10.59 | $26.41 2026-10-27 | +149.4% |
| 2021-11-15 | EPD | BUY | $1K–$15K | $22.92 | $37.17 2026-10-27 | +62.2% |
| 2021-11-11 | AM | BUY | $1K–$15K | $10.80 | $22.60 2026-09-04 | +109.3% |
| 2021-11-08 | NHI | BUY | $1K–$15K | $54.40 | $70.88 2026-09-04 | +30.3% |
| 2021-11-04 | T | BUY | $1K–$15K | $18.94 | $25.68 2026-09-04 | +35.6% |
| 2021-11-02 | T | BUY | $1K–$15K | $19.27 | $25.68 2026-09-04 | +33.3% |
| 2021-10-26 | SCU | BUY | $1K–$15K | $24.36 | $12.72 2023-11-16 | -47.8% |
| 2021-10-25 | SCU | BUY | $15K–$50K | $24.65 | $12.72 2023-11-16 | -48.4% |
| 2021-10-13 | MO | BUY | $1K–$15K | $47.92 | $68.88 2026-09-04 | +43.7% |
| 2021-10-08 | VIASP | BUY | $1K–$15K | $25.45 | $25.62 2026-07-09 | +0.7% |
| 2021-10-08 | GSK | BUY | $1K–$15K | $38.71 | $50.94 2026-10-27 | +31.6% |
| 2021-10-07 | OLP | BUY | $1K–$15K | $31.57 | $23.92 2026-09-04 | -24.2% |
| 2021-10-07 | DUKH | SELL | $50K–$100K | — | — | — exit |
| 2021-10-04 | PPL | BUY | $1K–$15K | $28.29 | $35.11 2026-09-04 | +24.1% |
| 2021-09-28 | PM | BUY | $15K–$50K | $98.42 | $182.53 2026-09-04 | +85.5% |
| 2021-09-27 | BP | BUY | $1K–$15K | $27.08 | $48.93 2026-10-27 | +80.7% |
| 2021-09-13 | XOM | BUY | $1K–$15K | $55.37 | $179.91 2026-10-27 | +224.9% |
| 2021-09-10 | ILPT | BUY | $15K–$50K | $26.18 | $7.38 2026-10-27 | -71.8% |
| 2021-08-16 | PAA | BUY | $1K–$15K | $9.73 | $26.41 2026-10-27 | +171.4% |
| 2021-08-13 | EPD | BUY | $1K–$15K | $22.52 | $37.17 2026-10-27 | +65.0% |
| 2021-08-11 | AM | BUY | $1K–$15K | $9.35 | $22.60 2026-09-04 | +141.7% |
| 2021-08-09 | XOM | BUY | $50K–$100K | $57.20 | $179.91 2026-10-27 | +214.5% |
| 2021-08-09 | PBA | BUY | $15K–$50K | $31.68 | $49.95 2026-10-27 | +57.7% |
| 2021-08-09 | NHI | BUY | $1K–$15K | $65.44 | $70.88 2026-09-04 | +8.3% |
| 2021-08-09 | BXMT | BUY | $50K–$100K | $31.96 | $10.69 2026-10-27 | -66.5% |
| 2021-08-06 | NHI | BUY | $1K–$15K | $66.63 | $70.88 2026-09-04 | +6.4% |
| 2021-08-03 | T | BUY | $1K–$15K | $21.53 | $25.68 2026-09-04 | +19.3% |
| 2021-07-12 | OLP | BUY | $1K–$15K | $29.57 | $23.92 2026-09-04 | -19.1% |
| 2021-07-12 | MO | BUY | $1K–$15K | $47.49 | $68.88 2026-09-04 | +45.0% |
| 2021-07-09 | GSK | BUY | $1K–$15K | $40.16 | $50.94 2026-10-27 | +26.8% |
| 2021-07-01 | PPL | BUY | $1K–$15K | $28.26 | $35.11 2026-09-04 | +24.2% |
| 2021-06-21 | BP | BUY | $1K–$15K | $26.94 | $48.93 2026-10-27 | +81.6% |
| 2021-05-27 | TPCO | SELL | $15K–$50K | $17.26 | — | — exit |
| 2021-05-27 | NHI | BUY | $15K–$50K | $65.56 | $70.88 2026-09-04 | +8.1% |
| 2021-05-17 | PAA | BUY | $1K–$15K | $10.45 | $26.41 2026-10-27 | +152.7% |
| 2021-05-13 | EPD | BUY | $1K–$15K | $23.61 | $37.17 2026-10-27 | +57.4% |
| 2021-05-13 | AM | BUY | $1K–$15K | $9.22 | $22.60 2026-09-04 | +145.1% |
| 2021-05-12 | NHI | BUY | $15K–$50K | $65.65 | $70.88 2026-09-04 | +8.0% |
| 2021-05-04 | T | BUY | $1K–$15K | $24.45 | $25.68 2026-09-04 | +5.0% |
| 2021-05-03 | MO | BUY | $1K–$15K | $48.37 | $68.88 2026-09-04 | +42.4% |
| 2021-04-19 | NHI | BUY | $50K–$100K | $73.27 | $70.88 2026-09-04 | -3.3% |
| 2021-04-13 | T | BUY | $1K–$15K | $22.63 | $25.68 2026-09-04 | +13.5% |
| 2021-04-09 | GSK | BUY | $1K–$15K | $36.65 | $50.94 2026-10-27 | +39.0% |
Buys are marked to the latest close and treated as still open. A sell tagged rt closes an earlier disclosed buy in the same name. exit reads from the seller's side: how the stock moved after they were out.
| Member | Shared tickers |
|---|---|
| Rohit Khanna | 64 · PBI, ADM, CI, PEP, ABT, CAT |
| Alan Armstrong | 41 · CI, PEP, ABT, FDX, GLW, MO |
| David A Perdue , Jr | 37 · PEP, CAT, FDX, GLW, MO, MOS |
| James B. Renacci | 30 · FET, CI, PEP, SPB, ABT, CAT |
| Thomas H Tuberville | 29 · AA, ADM, PEP, FDX, ODFL, ONEQ |
| Michael T. McCaul | 27 · AA, PEP, ABT, FDX, IWM, PFE |
| Thomas R Carper | 27 · PEP, ABT, GLW, MO, MOS, F |
| Kenny Marchant | 26 · AA, ABT, MOS, F, IWM, PFE |
| SUSAN M COLLINS | 24 · PEP, CAT, FDX, DUK, PFE, T |
| K. Michael Conaway | 24 · ADM, PEP, ABT, FDX, MO, F |
| Sheldon Whitehouse | 22 · PEP, ABT, CAT, MO, F, PFE |
| David P. Roe | 22 · PEP, CBRL, F, BP, DUK, PFE |